| Year |
Title |
Altmetric |
| 2023
|
Author Correction: Protein-based profiling of the human IgA1 clonal repertoire revealed shared clones of serum polymeric IgA1 and milk secretory IgA1 (Cellular & Molecular Immunology, (2023), 20, 3, (305-307), 10.1038/s41423-022-00965-z).
Cellular and Molecular Immunology.
20:310.
2023
|
|
| 2023
|
Protein-based profiling of the human IgA1 clonal repertoire revealed shared clones of serum polymeric IgA1 and milk secretory IgA1.
Cellular and Molecular Immunology.
20:305-307.
2023
|
|
| 2022
|
Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits.
Nature Communications.
13.
2022
|
|
| 2022
|
Phosphatase control of cytokine-mediated overproduction of galactose-deficient IgA1, the main autoantigen in IgA nephropathy.
Journal of Autoimmunity.
132.
2022
|
|
| 2022
|
Cytokines and Production of Aberrantly O-Glycosylated IgA1, the Main Autoantigen in IgA Nephropathy.
Journal of Interferon and Cytokine Research.
42:301-315.
2022
|
|
| 2021
|
Pathogenesis of iga nephropathy: Current understanding and implications for development of disease-specific treatment.
Journal of Clinical Medicine.
10.
2021
|
|
| 2021
|
Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
Journal of Autoimmunity.
118.
2021
|
|
| 2021
|
Immunoglobulin A Glycosylation and Its Role in Disease
2021
|
|
| 2020
|
Assigning immunoglobulin class from single-cell transcriptomes in IgA1-secreting versus membrane subpopulations
2020
|
|
| 2019
|
Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression (PLoS One (2019) 14:2 (e0212254) DOI: 10.1371/journal.pone.0212254).
PLoS One.
14.
2019
|
|
| 2019
|
Glycosylation in health and disease.
Nature Reviews Nephrology.
15:346-366.
2019
|
|
| 2019
|
Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression.
PLoS One.
14.
2019
|
|
| 2018
|
Assay for galactose-deficient IgA1 enables mechanistic studies with primary cells from IgA nephropathy patients
2018
|
|
| 2017
|
GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway.
PLoS Genetics.
13.
2017
|
|
| 2017
|
Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy.
Kidney International Reports.
2:1194-1207.
2017
|
|
| 2016
|
Markers for the progression of IgA nephropathy.
Journal of Nephrology.
29:535-541.
2016
|
|
| 2016
|
The origin and activities of IgA1-containing immune complexes in IGA nephropathy.
Frontiers in Immunology.
7.
2016
|
|
| 2016
|
Somatic mutations modulate autoantibodies against galactose-deficient IgA1 in IgA nephropathy.
Journal of the American Society of Nephrology.
27:3278-3284.
2016
|
|
| 2016
|
Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study.
Disease Markers.
2016.
2016
|
|
| 2015
|
New Insights into the Pathogenesis of IgA Nephropathy..
Kidney Diseases.
1:8-18.
2015
|
|
| 2014
|
Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease.
Journal of Immunology Research.
2014.
2014
|
|
| 2013
|
Mitochondrially targeted compounds and their impact on cellular bioenergetics.
Redox Biology.
1:86-93.
2013
|
|
| 2011
|
Assessing bioenergetic function in response to oxidative stress by metabolic profiling.
Free Radical Biology and Medicine.
51:1621-1635.
2011
|
|
| 2010
|
Prevention of diabetic nephropathy in Ins2+/-AkitaJ mice by the mitochondria-targeted therapy MitoQ.
Biochemical Journal.
432:9-19.
2010
|
|
| 2009
|
Methods for the determination and quantification of the reactive thiol proteome.
Free Radical Biology and Medicine.
47:675-683.
2009
|
|
